Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis.

Wagnerberger S, Spruss A, Kanuri G, Volynets V, Stahl C, Bischoff SC, Bergheim I.

Br J Nutr. 2012 Jun;107(12):1727-38. doi: 10.1017/S0007114511004983. Epub 2011 Oct 10.

PMID:
22018861
2.

Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.

Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I.

Hepatology. 2009 Oct;50(4):1094-104. doi: 10.1002/hep.23122.

PMID:
19637282
3.

Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice.

Spruss A, Kanuri G, Uebel K, Bischoff SC, Bergheim I.

Antioxid Redox Signal. 2011 Jun;14(11):2121-35. doi: 10.1089/ars.2010.3263. Epub 2011 Mar 16.

PMID:
21083420
4.

Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.

Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I.

Lab Invest. 2011 Jun;91(6):885-95. doi: 10.1038/labinvest.2011.44. Epub 2011 Mar 21.

5.

Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model.

Wagnerberger S, Spruss A, Kanuri G, Stahl C, Schröder M, Vetter W, Bischoff SC, Bergheim I.

J Nutr Biochem. 2013 Mar;24(3):531-8. doi: 10.1016/j.jnutbio.2012.01.014. Epub 2012 Jun 27.

PMID:
22749137
6.

Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.

Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I.

J Nutr Biochem. 2011 Jun;22(6):527-34. doi: 10.1016/j.jnutbio.2010.04.007. Epub 2010 Aug 30.

PMID:
20801629
7.

Cinnamon extract protects against acute alcohol-induced liver steatosis in mice.

Kanuri G, Weber S, Volynets V, Spruss A, Bischoff SC, Bergheim I.

J Nutr. 2009 Mar;139(3):482-7. doi: 10.3945/jn.108.100495. Epub 2009 Jan 6.

8.

Protective effect of bile acids on the onset of fructose-induced hepatic steatosis in mice.

Volynets V, Spruss A, Kanuri G, Wagnerberger S, Bischoff SC, Bergheim I.

J Lipid Res. 2010 Dec;51(12):3414-24. doi: 10.1194/jlr.M007179. Epub 2010 Sep 16.

9.

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.

Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I.

Lab Invest. 2012 Jul;92(7):1020-32. doi: 10.1038/labinvest.2012.75. Epub 2012 Apr 23.

10.

Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice.

Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, Bergheim I.

Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G335-44. doi: 10.1152/ajpgi.00088.2009. Epub 2009 Aug 27.

12.

Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.

Sellmann C, Priebs J, Landmann M, Degen C, Engstler AJ, Jin CJ, Gärttner S, Spruss A, Huber O, Bergheim I.

J Nutr Biochem. 2015 Nov;26(11):1183-92. doi: 10.1016/j.jnutbio.2015.05.011. Epub 2015 Jun 16.

PMID:
26168700
13.

Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC, Bergheim I.

J Nutr. 2008 Aug;138(8):1452-5.

14.

Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver.

Gustot T, Lemmers A, Moreno C, Nagy N, Quertinmont E, Nicaise C, Franchimont D, Louis H, Devière J, Le Moine O.

Hepatology. 2006 May;43(5):989-1000.

PMID:
16628628
15.

Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes.

Campo GM, Avenoso A, Campo S, D'Ascola A, Nastasi G, Calatroni A.

Biochimie. 2010 Feb;92(2):204-15. doi: 10.1016/j.biochi.2009.10.006. Epub 2009 Oct 29.

PMID:
19879319
16.

Oral intake of chicoric acid reduces acute alcohol-induced hepatic steatosis in mice.

Landmann M, Kanuri G, Spruss A, Stahl C, Bergheim I.

Nutrition. 2014 Jul-Aug;30(7-8):882-9. doi: 10.1016/j.nut.2013.11.015. Epub 2013 Dec 5.

PMID:
24985007
17.

Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.

Kanuri G, Ladurner R, Skibovskaya J, Spruss A, Königsrainer A, Bischoff SC, Bergheim I.

Liver Int. 2015 Feb;35(2):562-8. doi: 10.1111/liv.12442. Epub 2014 Jan 12.

PMID:
24351080
19.

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.

Trebicka J, Racz I, Siegmund SV, Cara E, Granzow M, Schierwagen R, Klein S, Wojtalla A, Hennenberg M, Huss S, Fischer HP, Heller J, Zimmer A, Sauerbruch T.

Liver Int. 2011 Jul;31(6):860-70. doi: 10.1111/j.1478-3231.2011.02496.x. Epub 2011 Mar 8.

PMID:
21645218
20.

Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice.

Jin CJ, Engstler AJ, Ziegenhardt D, Bischoff SC, Trautwein C, Bergheim I.

J Gastroenterol Hepatol. 2017 Mar;32(3):708-715. doi: 10.1111/jgh.13488.

PMID:
27404046

Supplemental Content

Support Center